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Background
Preparations from Echinacea are among the best-selling
phytopharmaceuticals worldwide and have been widely
used for the treatment of common cold and various upper
respiratory infections. The most relevant active principles
of Echinacea extracts are alkamides, caffeic acid derivatives
(CADs) and glycoproteins/polysaccharides [1]. The main
alkamides in Echinacea preparations are the isomeric
dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides
(''tetraenes''). Until now, a limited number of pharmacok-
inetic studies with alkamides have been reported, but no
data exist about their distribution in tissues and transport
through the blood-brain barrier (BBB). Therefore, we eval-
uated the pharmacokinetics of dodeca-2E,4E,8E,10E/Z-
tetraenoic acid isobutylamides after a single oral dose
administration of 2.5 mg/kg in plasma as well as in liver
and four different brain regions (hippocampus, cerebral
cortex, striatum and cerebellum).
Methods
Plasma and tissues were collected after 8, 15, 30 minutes
and 1, 2, 3, and 6 hours after oral dosing and the concen-
trations were determined by a liquid chromatography tan-
dem mass spectrometry (LC-MS/MS) method with
benzanilide as internal standard using the respective [M-
H]+ ions, m/z 248/152 for the dodeca-2E,4E,8E,10E/Z-
tetraenoic acid isobutylamides and m/z 198/105 for the
internal standard.
Results
The liphophilic constituents were rapidly absorbed and
well distributed to the examined tissues. The highest con-
centration was found in the striatum. The total tetraene
amount in plasma was calculated as AUC0-∞ (794
min·ng/mL), which was about 13-45% of that found in
different brain parts (1764-6192 min·ng/mL), and 63%
of that in liver tissues (1254 min·ng/g). The Cmax in
plasma was 26.4 ng/mL, while the Cmax in the different
brain regions varied between 33.8 ng/g and 46.0 ng/g.
Conclusion
The results demonstrate that the dodeca-2E,4E,8E,10E/Z-
tetraenoic acid isobutylamides are bioavailable in rats
with a rapid passage across the blood-brain barrier.
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